FDA OKs 3T full-body scans labeling for Axonics r-SNM System

The FDA has approved Axonics Modulation Technologies’ (NASDAQ:AXNX) supplemental marketing application for 3T full-body magnetic resonance imaging (MRI) conditional labeling for the Axonics r-SNM System.

The agency approved labeling for 1.5T MRI scanners in September 2019.

https://seekingalpha.com/news/3587988-fda-oks-3t-full-body-scans-labeling-for-axonics-r-snm-system